(2R)-2-[[6-[[(5-Methylthiophen-2-yl)methyl]amino]-9-propyl-9H-purin-2-yl]amino]butan-1-ol - Names and Identifiers
(2R)-2-[[6-[[(5-Methylthiophen-2-yl)methyl]amino]-9-propyl-9H-purin-2-yl]amino]butan-1-ol - Physico-chemical Properties
Molecular Formula | C18H26N6OS
|
Molar Mass | 374.5 |
Density | 1.33±0.1 g/cm3(Predicted) |
Boling Point | 599.6±60.0 °C(Predicted) |
Solubility | 10 mM in DMSO |
pKa | 14.56±0.10(Predicted) |
Storage Condition | -20℃ |
(2R)-2-[[6-[[(5-Methylthiophen-2-yl)methyl]amino]-9-propyl-9H-purin-2-yl]amino]butan-1-ol - Preparation solution concentration reference
| 1mg | 5mg | 10mg |
---|
1 mM | 2.67 ml | 13.351 ml | 26.702 ml |
5 mM | 0.534 ml | 2.67 ml | 5.34 ml |
10 mM | 0.267 ml | 1.335 ml | 2.67 ml |
5 mM | 0.053 ml | 0.267 ml | 0.534 ml |
Last Update:2024-01-02 23:10:35
(2R)-2-[[6-[[(5-Methylthiophen-2-yl)methyl]amino]-9-propyl-9H-purin-2-yl]amino]butan-1-ol - Reference Information
biological activity | GV-58 are N-and P/Q-type calcium channel agonists, with EC50 values of 7.21 and 8.81uM respectively, and their inhibitory effect on CDK kinases is 20 times weaker, which is the optimized compound of (R)-roscovitine. |
Last Update:2024-04-09 20:52:54